| Literature DB >> 18760699 |
Hansen Wang1, Long-Jun Wu, Susan S Kim, Frank J S Lee, Bo Gong, Hiroki Toyoda, Ming Ren, Yu-Ze Shang, Hui Xu, Fang Liu, Ming-Gao Zhao, Min Zhuo.
Abstract
The fragile X mental retardation protein (FMRP) is an RNA-binding protein that controls translational efficiency and regulates synaptic plasticity. Here, we report that FMRP is involved in dopamine (DA) modulation of synaptic potentiation. AMPA glutamate receptor subtype 1 (GluR1) surface expression and phosphorylation in response to D1 receptor stimulation were reduced in cultured Fmr1(-/-) prefrontal cortex (PFC) neurons. Furthermore, D1 receptor signaling was impaired, accompanied by D1 receptor hyperphosphorylation at serine sites and subcellular redistribution of G protein-coupled receptor kinase 2 (GRK2) in both PFC and striatum of Fmr1(-/-) mice. FMRP interacted with GRK2, and pharmacological inhibition of GRK2 rescued D1 receptor signaling in Fmr1(-/-) neurons. Finally, D1 receptor agonist partially rescued hyperactivity and enhanced the motor function of Fmr1(-/-) mice. Our study has identified FMRP as a key messenger for DA modulation in the forebrain and may provide insights into the cellular and molecular mechanisms underlying fragile X syndrome.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18760699 DOI: 10.1016/j.neuron.2008.06.027
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173